Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice T C Freeman, R J Playford, C Quinn, K Beardshall, L Poulter, J Young, J Calam Abstract We studied the distribution of pancreatic secretory trypsin inhibitor (PSTI) in the epithelia of the gastrointestinal tract and determined whether PSTI is secreted into gastric juice. PSTI was measured by a specific radioimmunoassay in biopsy specimens taken from the upper (n=8) and lower (n=7) gastrointestinal tract of patients with normal endoscopies. PSTI was present in the stomach, small intestine, and colon. Concentrations (1ig/g protein) were highest in the stomach, and significantly higher in the antrum (1240, 670-1700, median and range) than in the gastric body (370, 350-570) (p<001). Concentrations were similar in the duodenum (180, 80-210) and colon (160, 130-360). PSTI determined by immunohistochemistry was present in mucus secreting gastric foveolar cells, duodenal Paneth cells, and colonic non mucus cells. PSTI was present in gastric juice. The median (range) concentration of PSTI in basal gastric juice from 13 patients with duodenal ulcers was 9 (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) .tg/l and did not change during stimulation with pentagastrin. The rate of secretion, however, did increase significantly (p<0c05) from 1430 (180-2810) ng/h to 4500 (1250-12 770) ng/h during pentagastrin stimulation. PSTI was labile in acid pepsin but stable in the neutral conditions present in the mucus layer. The presence of pancreatic secretory trypsin inhibitor throughout the gut and its secretion into the lumen suggests a hitherto unrecognised mechanism protecting gastrointestinal epithelia against luminal proteases. 16 January 1990 Pancreatic secretory trypsin inhibitor (PSTI) is a small protein containing 56 amino acid residues which was originally isolated from bovine pancreas,' and human PSTI has now been purified24 and cloned.5 PSTI is thought to protect the pancreas from prematurely activated proteases but the recent demonstration of PSTI-like immunoreactivity (PSTI-LI) in other regions of the gut"8 and its isolation from the human stomach,9 suggests that PSTI may protect the whole gastrointestinal tract.
The present study was undertaken to determine epithelial concentrations of PSTI using biopsy specimens obtained from the stomach, small intestine, and colon and to study the cellular distribution of PSTI-LI. We also analysed gastric juice to determine whether PSTI is secreted into the lumen.
Methods
The local ethics committee approved the protocol and all patients gave informed consent.
All chemicals were purchased from BDH (Poole, Dorset) unless otherwise stated. with '25I by the chloramine T method" and tracer, 1500 cpm/tube, was incubated with antiserum T4 (final dilution 1:500 000) together with PSTI standards (0-01-50 ng/ml) or samples in 1 ml of sodium phosphate buffer (0 5 M, pH 7 3) containing 0-15% bovine serum albumin (Sigma) and 0 02% sodium azide. Incubation was at 4°C for 3 days and separation was achieved by adding to each tube at 40C, 100 pl of ethylenediamine tetra-acetate (EDTA) (0 1 M, pH 7 3), 100 RI of 2% rabbit serum in assay buffer, 100 ptl of second antibody (goat antirabbit antiserum, type R 0881, Sigma) diluted 1:5 in assay buffer, and 700 p1l of 6% polyethylene glycol 6000 in albumin free assay buffer. The tubes were mixed and incubated at 40C for 40 minutes before being centrifuged at 3500 g and 40C for I5 minutes. The supernatant was aspirated into separate tubes and both tubes counted.
COLLECTION AND EXTRACTION OF ENDOSCOPIC BIOPSY SPECIMENS
Upper gastrointestinal biopsy specimens were collected during routine endoscopy, using FB25K forceps (Keymed, Southend-on-Sea, Essex), from eight patients, three men and five women, mean age 46 years (range 32-61 years). These patients were under investigation for dyspepsia, but endoscopy and other investigations proved normal and the final diagnosis was non-ulcer dyspepsia. Paired endoscopic biopsy specimens were normal on histological examination. No patients took any drugs within two days of the examination. The mean (SD) weight of the biopsy specimens was 6 8 (2 0) mg.
Lower gastrointestinal biopsy specimens were collected during routine endoscopy, using FG15L forceps (Keymed), from seven patients, four men and three women, mean age 47 years (range 26-65 years). These patients were under investigation for abdominal pain or disturbance of bowel habit, but endoscopy and other investigations showed no abnormality and the final diagnosis was the irritable bowel syndrome. Paired endoscopic biopsy specimens were normal on histological examination. None of the patients took any drugs during the two days before examination except for a bowel preparation, which comprised a low residue diet, two sachets of Picolax (Ferring, Feltham, Middx), and GASTRIC JUICE Gastric juice was collected during routine pentagastrin tests on 18 patients, 13 men and five women, in whom duodenal ulcers had been seen at endoscopy within seven days of study. Their mean age was 49 years (range 25-77 years). None took any drugs in the two days before the study.
Gastric juice was collected from the last of three 10 minute basal collections and after stimulation with pentagastrin 0-6 rig/kg per hour for at least 80 minutes. Juice (2 ml) was collected directly from the aspiration tube, and immediately neutralised by mixing with 3 ml 0-17 M sodium bicarbonate on ice. Samples were then frozen at -20°C before assay.
Gastric juice samples were analysed for bilirubin with a RA-1000 analyser (Technical Instrument Corporation), using Technicon method, number SM-0179887. Tryptic activity was determined by the pH stat method using Nap-tosyl-L-arginine methyl ester (Sigma) as substrate. ' Figure 4 , 250 p1 samples were removed, immediately neutralised by addition of an equal volume of 0-17 M sodium bicarbonate, frozen on solid CO2, and stored at -200C until radioimmunoassay. In control studies PSTI was incubated as already described, but in Tris-HCI buffer at pH 2-0 and 4 0.
The stability of PSTI in unbuffered gastric The interassay and intra-assay variabilities of the radioimmunoassay were 17% and 8% respectively. The detection limit of the assay was 0.05 ng/tube. The binding of tracer to antibody was not inhibited by bovine trypsinogen (Sigma), human epidermal growth factor (donated by H Gregory), soybean trypsin inhibitor (Sigma), or canine PSTI (purified by author) (Fig 2) . The ratios of cross reactivity of the different forms to peak III were I: 0 70: 1, II: 0-86:1.
CONCENTRATIONS OF PSTI-LI IN ENDOSCOPIC BIOPSY SPECIMENS
The concentrations of PSTI-LI in biopsy specimens taken from different regions of the human gastrointestinal tract, expressed as [tg/g wet weight and lig/g protein in extracts, are shown in Table I . PSTI-LI was undetectable in specimens from the oesophagus, but the stomach contained the most PSTI-LI, the concentration being significantly greater in the antrum than in the body of the stomach (p<001). Concentrations of PSTI-LI were similar in the duodenum and colon. There was no significant difference between mucosal concentrations of PSTI-LI in the first and second parts of the duodenum, or between the regions of the colon. The median (range) concentration for each patient was 180 (80-210) tig/g protein in the duodenum and 160 [ig/g protein in the colon.
SECRETION AND STABILITY OF PSTI-LI IN GASTRIC JUICE
Trypsin was not detected in any sample ofgastric juice. One sample which contained bilirubin was excluded from analysis. PSTI-LI was,detected in gastric juice from all patients. The concentration of PSTI-LI in basal juice was not significantly changed during stimulation with pentagastrin (Table II) . Because of the increase in the volume of juice secreted, however, the output of PSTI-LI rose significantly (p<005) after stimulation with pentagastrin (Fig 3) . PSTI-LI was labile in acidic gastric juice (Fig 4) . The disappearance half times were less than 1 minute at pH 2-0, but about 2 hours at pH 4. There was no detectable loss of PSTI in gastric juice at pH 6-0 and 7-4 in 24 hours. There was no detectable loss of PSTI-LI after incubation in Tris buffer at pH 2O0 and 4'0 in the absence of gastric juice for 24 hours. After incubation of PSTI in unbuffered gastric juice, pH 1-4 for 1 hour in the presence of pepstatin, 81% of original immunoreactivity remained. No PSTI-LI was detectable in the control tube without pepstatin. duodenum, and colon but undetectable in the oesophagus. Tissue concentrations were greatest in the gastric antrum. PSTI-LI was found to be in a specific cell type in each region of the gut. We have shown for the first time that PSTI is secreted into the lumen of the stomach. PSTI is rapidly destroyed by acid pepsin but stable at the neutral pH found in the gastric mucus layer.
In a previous study Shibata et al measured PSTI-LI in cadaveric small intestine and surgically resected stomach,6 and found concentrations over an order of magnitude lower than in the present study. The lower concentrations that they reported may have been due to loss of PSTI through hydrolysis by' mucosal enzymes before extraction and a higher proportion of submucosal tissues in samples.
The cellular distribution of gastrointestinal PSTI-LI reported in the present study is consistent with the main findings of two other groups.78 The weak PSTI-LI seen by' others, however, in the goblet cells of the colon and in other gastric cell types, including chief cells, was not observed in the present study.
We are not awaie of any previous report of the secretion of PSTI into gastric juice. The concentrations of PSTI-LI in gastric juice did not rise significantly during the infusion of pentagastrin, although there was a significant increase in the output of gastric PSTI. Pentagastrin has been reported to increase gastric secretion of carbohydrate from the same cell type in the cat. 16 In the present study PSTI was shown to be rapidly destroyed by pepsin in gastric juice at acid pH, but stable if the juice was neutralised. PSTI probably exerts its protective effect in the gastric mucus layer which is kept at a neutral pH due to gastric secretion of bicarbonate."7 Hydrolysis of PSTI by pepsin is probably responsible for the rapid loss of PSTI-LI in acidic extracts of gastric mucosa that was reported by Shibata et 
The results ofthe present analytical studies are consistent with the results of others who have shown that pancreatic PSTI exists in multiple forms.23 These differ chiefly in the degree of deamination ofthe asparagine residues which are unusually abundant in PSTI. Fraction III and II2 had the predicted mass of the molecule whereas fractions I and III had a molecular mass consistent with monodeaminated PSTI. In addition, Kikuchi et al found a form of PSTI in pancreatic juice which had five amino acids missing from the N-terminal, which was not found here. 2 The presence of PSTI in all regions of the gut, and its secretion into the lumen, suggest that PSTI may protect the whole gut from proteolytic enzymes. Gastric PSTI is presumably important during episodes of duodenogastric reflux which occur in health,'8 occur more frequently in some diseases such as gastric ulcer,'9 and occur more or less constantly after some forms of gastric surgery.'9 Reflux of duodenal juice may raise intragastric pH to levels at which pancreatic enzymes are active but PSTI is stable. Concentrations of PSTI measured in pancreatic juice in the present study were similar to those reported by others3 and approximately 1000 times higher than concentrations found in gastric juice. Concentrations of PSTI in the gastric mucusbicarbonate layer, however, may be considerably higher than those found in the lumen of the stomach. In addition, the concentration of trypsin entering the mucus layer may be diminished by dilution and by peptic destruction of trypsin in the lumen of the stomach.20 It is interesting that gastric mucosal PSTI is most abundant in the antrum, which is most exposed to refluxed enzymes. Colonic PSTI may protect the colonic epithelium from pancreatic enzymes which remain active in colonic contents.2' PSTI also inhibits elastase and chymotrypsin4 as well as trypsin.
Recent work has shown that PSTI is a growth fa&u(r'J as well as a protease inhibitor. We showed tB it hmnan PSTI 
